Novavax, Inc. (NVAX)

8.00 -0.67 (-7.73%) USD  |  NASDAQ  |  Jan 14, 11:45
More

Novavax Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for NVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Moderna, Inc. Upgrade
Merck & Co., Inc. Upgrade
Arcturus Therapeutics Holdings, Inc. Upgrade
Denali Therapeutics, Inc. --